医学文献 >>
  • 检索发现
  • 增强检索
知识库 >>
  • 临床诊疗知识库
  • 中医药知识库
评价分析 >>
  • 机构
  • 作者
默认
×
热搜词:
换一批
论文 期刊
取消
高级检索

检索历史 清除

Is the 0.80% graft-to-recipient weight threshold still relevant in modern adult living donor liver transplantation?

摘要The graft-to-recipient weight ratio(GRWR)threshold of 0.80%has long been used to guide graft selection in adult living donor liver transplantation(LDLT)as a pragmatic surrogate for graft adequacy.However,expanding use of donor-sparing left liver grafts and advances in perioperative management have chal-lenged the universality of this cutoff.This review re-examines the relevance of the 0.80%GRWR thresh-old in modern adult LDLT,focusing on the evolving pathophysiology of small-for-size syndrome,the role of portal hyperperfusion and secondary hepatic arterial hypoperfusion mediated through the hepatic ar-terial buffer response,and the clinical impact of hemodynamic monitoring and inflow modulation.We summarized surgical and pharmacologic strategies to optimize portal and arterial inflow and proposed practical hemodynamic targets(e.g.,portal venous flow<5 mL/min per gram graft and portal venous pressure<20 mmHg with preserved hepatic arterial inflow).To provide real-world context,the authors integrated original data from their institutional left-graft LDLT cohort(n=202,median GRWR 0.72%,range 0.39%-1.48%),including recipients with GRWR<0.80%(n=152,75.2%)and<0.60%(n=44,21.8%).Small-for-size syndrome occurred in 56.9%of recipients.GRWR<0.80%was not associated with the incidence of small-for-size syndrome(60.5%vs.46.0%,P=0.102)or in-hospital mortality(8.6%vs.6.0%,P=0.765),and long-term survival was comparable across GRWR groups when portal inflow was controlled and hepatic arterial perfusion preserved.Overall,GRWR remains useful for risk stratification but should not function as an absolute cutoff,rather a physiology-driven,hemodynamic-guided strategy may better define graft adequacy in modern adult LDLT.

更多
广告
提交
  • 浏览0
  • 下载0
国际肝胆胰疾病杂志(英文版)

加载中!

相似文献

  • 中文期刊
  • 外文期刊
  • 学位论文
  • 会议论文

加载中!

加载中!

加载中!

加载中!

法律状态公告日 法律状态 法律状态信息

特别提示:本网站仅提供医学学术资源服务,不销售任何药品和器械,有关药品和器械的销售信息,请查阅其他网站。

  • 客服热线:4000-115-888 转3 (周一至周五:8:00至17:00)

  • |
  • 客服邮箱:yiyao@wanfangdata.com.cn

  • 违法和不良信息举报电话:4000-115-888,举报邮箱:problem@wanfangdata.com.cn,举报专区

官方微信
万方医学小程序
new医文AI 翻译 充值 订阅 收藏 移动端

官方微信

万方医学小程序

使用
帮助
Alternate Text
调查问卷